Maplight Therapeutics Inc (MPLT)

R&D Expenses

$198.70M

TTM · Period ending: · USD

MPLT logo

MPLT R&D Expenses

Latest reported$198.70M
MPLT R&D Expenses ($26.57M → $198.70M)
High-resolution chart · PNG

MPLT r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Maplight Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
137,771,000
67,822,000
49,119,000
26,570,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.